Team

Ernesto Chanona, Ph.D.

CEO, American Business Development

Ernesto Chanona is the CEO of American Business Development Corporation (ABD), where he helps service providers optimize their business development operations, streamline client acquisition, and establish scalable growth strategies. Under his leadership, ABD develops, implements, and instructs companies on building internal BD functions while also providing outsourced business development solutions, including conference representation, strategic outreach, and prospect handoff services.

Before founding ABD, Ernesto served as Vice President of Business Development & Alliance Management at CSSi LifeSciences, where he specialized in forging strategic partnerships with innovation hubs, international government agencies, academic institutions, and entrepreneurs. He previously led international trade efforts at the Maryland Department of Commerce, assisting biotechnology, pharmaceutical, and medical device companies with recruitment, expansion, and export activities.

Ernesto trained as a cancer immunologist, developing immunotherapies for colorectal cancer and melanoma at the National Cancer Institute. He holds a PhD in pharmacology from the University of North Carolina at Chapel Hill and a Bachelor’s degree from Johns Hopkins University.

In addition to leading ABD, Ernesto was appointed by the Governor of Maryland as Chairman of the Commission on Hispanic Affairs, where he advises on policy matters impacting Maryland’s Hispanic community. He also serves as an Adjunct Professor at Johns Hopkins University, sharing his expertise in business development and life sciences commercialization.

Andrew Nelson, PhD

Chief Operating Officer

Andy Nelson is Chief Operating Officer at ABD, leveraging his diverse background to streamline operations and ensure successful client outcomes. He focuses on the critical task of optimizing the alignment between client timelines and internal team resources.

Andy’s professional foundation includes strategic program management in workforce development for the microchip industry, as well as extensive experience in market research and technical consulting for immunoassay companies.

He is a trained immunologist, having earned his Ph.D. in Veterinary Medicine from the University of Florida. His doctoral research centered on developing immunotherapies for Type 1 Diabetes and Sjögren’s syndrome.

Zain Rana

Executive Consultant, Japan Strategy & Partnerships

Zain Rana serves is the Executive Consultant for the Japanese market at ABD. He drives Japan–US cross-border strategy for biotechnology and pharmaceutical companies. His work focuses on oncology, rare diseases, and advanced therapeutics, supporting clients with new market entry, the establishment and scale-up of cell processing and manufacturing capabilities, and the development of high-performance R&D and commercial teams.

He also serves as an Advisor to BioCommunity Kansai, contributing to the growth of the Kansai bio-economy and strengthening international collaboration between academia, startups, and global industry partners.

In addition to his industry roles, Zain is a Guest Lecturer at Kyoto University, where he engages with researchers and entrepreneurs on the topics of translational science, commercialization strategy, and global biotech ecosystems.

He further provides strategic fundraising and business development support to early-stage biotech companies, assisting founders with investor-ready materials, capital-raising strategy, and connections to venture capital partners. With hands-on oncology research experience and a strong academic foundation in molecular medicine, he brings a science-driven approach to commercial strategy, helping innovative biotech ventures translate breakthrough ideas into global market impact.

Dr. Christopher Speller is a senior executive leader with 20+ years of experience driving organizational transformation across government, defense, and industry. He specializes in aligning technology, operations, and executive strategy to deliver measurable, mission-focused results.

Christopher W. Speller, D.B.A.

Executive Consultant, U.S. Department of Defense Strategy and Partnerships

Chris Speller is the Executive Consultant for access and partnerships with the U.S. Department of Defense at ABD. He has led multi-million-dollar portfolios and major enterprise transformation efforts for the Department of War (DoW) and the Office of the Secretary of Defense (OSD). His work has advanced AI/ML adoption, shaped congressionally mandated programs, and strengthened national security, homeland defense, and crisis-response readiness.

Dr. Speller is recognized for translating complex strategies into actionable outcomes, improving performance, reducing costs, and accelerating innovation. His expertise spans policy development, interagency coordination, workforce development, technology transfer, and organizational change.

He also serves as a Board Advisor to the Don’t Mind Foundation and as a Public Member of the Board of Professional Responsibility for the U.S. Court of Appeals (D.C.). A retired U.S. Air Force professional, he brings operational discipline from both peacetime personnel roles and wartime contingency operations.

Dr. Speller holds a DBA in Global Business and Leadership, an M.A. in International Relations, and a B.B.A. in Business Administration, and completed Harvard’s Strategic Leadership Program. He continues to champion innovation, collaboration, and strategic vision to strengthen national security and public safety.

Seema Mangoo

Executive Consultant, UAE Strategy and Partnerships

Seema Mangoo is the Executive Consultant for UAE market at ABD.  She is an international business strategist and growth advisor with a proven record of helping companies expand and scale across global markets. As Managing Director of Hourglass Business Services, she works with startups, SMEs, and established firms to design and execute market entry strategies, forge cross-border partnerships, and accelerate commercial growth across the GCC and beyond. Seema brings over 15 years of experience spanning government, trade, and private sector roles across the UK and UAE. She has delivered strategic export support for the UK Government’s Department for Business and Trade, strengthened bilateral business engagement at AmCham Abu Dhabi, and now advises organisations on how to navigate the Gulf’s evolving regulatory and cultural landscape with confidence. Her work bridges strategy and execution, helping businesses identify opportunities, build networks, and translate plans into measurable results. Driven by a belief that growth is built on collaboration, Seema’s mission is to equip businesses with the connections and practical tools to succeed in new markets and create lasting international partnerships.

Sasha Whitaker

CMO, American Business Development

Sasha Whitaker is a results-driven marketing strategist known for building creative, integrated digital campaigns that deliver measurable growth. With deep expertise in design, website development, social media management, SEO, and advertising, Sasha partners with companies to drive high-impact marketing initiatives that achieve real business outcomes. She works closely with CEOs to build strategy, conceptualize intellectual property, and execute marketing programs that consistently exceed expectations.

Across client engagements, Sasha has driven millions of dollars in sales and investment through inbound marketing strategies, expanded brand reach through multi-channel campaigns, and accelerated digital growth. In one notable example, she quadrupled a client’s site traffic from 4,000 to over 16,000 sessions per month, doubled monthly inbound investor traffic, and generated more than 85 inbound investor-lead conversions—resulting in $795,000—from a single campaign. Her SEO expertise helped 67 of a client’s target keywords rank in the top three search results, dramatically improving their organic visibility.

Melissa Olivadoti, Ph.D.

Executive Consultant, Medical Affairs

Melissa Olivadoti is a PhD in Neuroscience with 14 years of direct experience working in a variety of Pharma and Device companies in various roles, along with 4 years of consulting. From Publications, to Field Medical, and Headquarters roles, Melissa has gathered expertise that allows her to be a swiss army knife for her clients and complete anything they need in Medical Affairs and scientific communication activities. Melissa specializes in working with early-phase companies to ensure their data is disseminated in an impactful way, utilizing targeted information sharing to establish strong KOL relationships, and creating powerful data presentations and materials to share the potential of the product. Melissa also specializes in pulling in critical insights from a variety of stakeholders to ensure the success of the product and program. She has a breadth of expertise in different disease states, and is able to communicate to different levels of stakeholders, from patients and caregivers to HCP experts. From creating strategy to carry out tactics, and solving for unexpected challenges, Melissa is serves her clients in the full suite of MA activities with great enthusiasm and care.

David Villiotti

CFO, American Business Development

David Villiotti has experience in a diverse range of industries and functions.  After earning his bachelor’s degree in business, he started his career running the daily ticket office operations for minor league baseball and college athletic teams.

While working he went back to school and earned a bachelor’s degree in accounting pivoting to a career in accounting starting with PriceWaterhouseCoopers then moving to Consol Energy.  While at Consol, he managed the royalty revenue recognition process and completed process improvements allowing the company to reduce the number of staff required to complete the process from 5 to 1 freeing the remaining staff to work on other projects.  While still at Consol he started to attend Carnegie Mellon University part time earning his MBA.

He then made another pivot and joined Allegheny Health Network as a project manager for the Chief Revenue Cycle Officer.  After only three months he was promoted to Director, Cash Management.  In this role he is currently over seeing all payment posting to the patient electronic medical records system (EMR).  He is currently in the middle of an installation of a new module in the EMR to automate the majority of the payment posting and reconciliation process.   The new process went live on February 1st of this year, and despite still being fine-tuned overtime was eliminated in the department without adding staff.

In December of 2016 David started Good Steward Accounting which was a full-service accounting firm serving clients nationwide that provided monthly accounting services and fractional CFO services to businesses as well as personal income tax preparation.  In June of 2023, David sold the accounting clients to focus on providing fractional CFO services and refining his skills with a smaller number of clients.

Then, in October of 2024, David started Villiotti Business Advisory Services (VBAS)where he brought together a team of individuals with incredible experience ranging from providing fractional CFO services for 20 years, to one of the founders of MarketWatch who helped build the company until it was sold to the Dow Jones.  VBAS provided fractional CFO services to businesses in any industry who are looking to grow.

Rosie Tilmont

Chief of Staff, Marketing & Strategic Initiatives, American Business Development

Rosie Tilmont is the Manger, Business Development at American Business Development Corporation (ABD), where she specializes in optimizing business development operations, alliance management, and strategic partnerships. With expertise in business strategy, lead generation, and client engagement, she helps service providers streamline their BD processes, build sustainable pipelines, and establish high-impact growth strategies.

Before joining ABD, Rosie served as a Business Development and Alliance Management Associate at CSSi LifeSciences, where she led strategic outreach efforts, managed industry partnerships, and supported clients in the life sciences sector. She played a key role in CRM integration, proposal development, and marketing alignment, ensuring business development efforts were both data-driven and client-focused.

Rosie holds a Master’s in Biotechnology Enterprise and Entrepreneurship from Johns Hopkins University (4.0 GPA) and a Bachelor’s in Neuroscience with minors in Business Administration and Spanish (Summa Cum Laude) from Christopher Newport University. Her background includes consulting roles, where she provided strategic business insights for biotech startups and international nonprofits, as well as industry experience with AstraZeneca, where she streamlined processes and implemented Six Sigma initiatives to improve operational efficiency.

With a proven track record in business development, client acquisition, and alliance management, Rosie is committed to helping companies optimize their business development strategies and achieve sustainable growth.

Robert Sons

Executive Consultant, Investor Relations

Robert Sons, PhD, has over 10 years of experience driving the commercialization of healthcare technologies to improve patient outcomes. He currently consults for startup biotechnology firms, providing leadership and support in business and corporate development, strategy, and operations. Previously, he contributed to business and corporate development at Rakuten Medical, a commercial-stage company developing drug-device combination therapies in oncology. At Fannin Innovation Studio, a venture creation firm, he supported search and evaluation efforts across drugs, devices, and diagnostics, and managed multiple programs’ development. He began his career in business development at the National Cancer Institute. Robert holds a PhD in Cell & Developmental Biology from UNC-Chapel Hill.

Mi Jeong Hibbitts

Executive Consultant, Business Development

Mi Jeong Hibbitts is the Founder and CEO of Robert & William, LLC, a Maryland-based international trade and market entry consulting firm specializing in bridging U.S. and Asian markets, with a strong emphasis on U.S.- South Korea trade and investment. With decades of experience across both the private and public sectors, Mi Jeong is a highly regarded global business development advisor and international marketing expert. She is known for her ability to connect businesses across borders and drive sustainable growth in competitive global markets.

Her deep expertise spans international trade, technology, advertising, marketing, media, journalism, finance, and public sector administration. Mi Jeong’s consulting practice focuses on helping companies enter and expand in the U.S. and Northeast Asian markets by providing strategic guidance, practical market insights, and valuable industry connections. She has supported over 100 South Korean companies across various sectors, including startups in emerging industries such as artificial intelligence, robotics, biotechnology, renewable energy, semiconductors, beauty/health, and food & beverage. Her services include market entry strategy development, business growth planning, and fundraising support, ranging from crowdfunding to venture capital.

As Executive Director of the Global Chamber® Baltimore/Washington, Mi Jeong leverages a global network of 525+ metro areas to connect her clients with meaningful international business opportunities.

Previously, she served as Director of International Sales and Marketing at PTC International, Inc., a U.S.- based international trade and marketing firm, where she managed multimillion-dollar campaigns for U.S. food and beverage suppliers expanding into dynamic Asian markets. She advised major South Korean conglomerates – including Lotte Confectionery, Lotte Foods, and Lotte R&D – on U.S. market trends, regulatory compliance, technology and product innovation.

In the public sector, Mi Jeong held administrative and business management roles at the U.S. Agency for Global Media (USAGM). She also served as a Congressional Correspondent for Voice of America, the U.S. government’s international broadcaster, where her high-profile interviews with U.S. policymakers on U.S.- Asia relations earned her widespread recognition and multiple accolades.

Her marketing career began at MBC AdCom, a premier South Korean advertising agency, where she managed top-tier accounts in industries including automotive, airlines, insurance, and cosmetics.

Mi Jeong holds a B.A. in English Language and Literature from Ewha Womans University in South Korea and earned her MBA from the University of Hawaii at Manoa through the prestigious East-West Center Scholarship, funded by the U.S. Congress.

Bilingual in English and Korean, Mi Jeong combines cultural fluency with global business acumen. Her extensive international experience and practical expertise make her a trusted advisor for companies seeking to enter or expand into cross-border markets.

Andrew Kennedy

Business Development Associate 

Andrew Kennedy is a Business Development Associate at ABD and a senior Ph.D. candidate at the University of North Carolina at Chapel Hill, where he researches cancer immunotherapies. With a background in biology and experience in drug delivery research, Andrew also brings a strong foundation in business strategy. He has led consulting projects through CGsquared, advising life sciences clients on operations and market entry. As Director of Digital Infrastructure for UNC’s graduate business organization, he oversees strategic data operations and digital engagement. Prior to ABD, he served as a Business Development Associate at the Center for Entrepreneurial Development. Andrew brings a unique blend of scientific rigor and commercial acumen to his role.

Logan Frayser

Business Development Fellow

Logan Frayser is a Business Development Fellow at American Business Development (ABD) and a Ph.D. candidate in Pharmacology & Physiology at Georgetown University. Previously, Logan earned his B.S. in Biotechnology with honors and a minor in Sociology from James Madison University, where he conducted research in motor planning and spinal reflexes. He has research experience in cell culture and non-human primate models and now focuses on developing therapeutics for cognitive impairments following traumatic brain injury using rodent models. Logan joined ABD through an NIH T32 training grant and is passionate about public outreach and advancing the translation of scientific innovation into real-world impact.

Ameneh Arabi

Business Development Associate 

Ameneh Arabi is a Business Development Associate at American Business Development (ABD), where she combines a deep scientific background with strategic insight to support early-stage value creation. A biomedical scientist with over nine years of experience in immunotherapy, nanomedicine, and translational oncology, Ameneh has led preclinical research efforts at Johns Hopkins and WWAMI, advancing cancer vaccines, nanoparticle delivery systems, and immune-modulating therapies. She holds a Ph.D. in Biochemistry and an M.Sc. in Organic Chemistry and has co-authored numerous peer-reviewed publications. Ameneh excels at bridging technical expertise with commercial strategy and is passionate about translating research into real-world impact through partnerships and innovation.

Anjik Bose

Business Development Associate 

Anjik Bose is a Business Development Associate at ABD and a Ph.D. candidate in Pharmacology & Physiology at Georgetown University. His research focuses on developmental neurotoxicity in neonatal patients, with experience in zebrafish, rodent, and non-human primate models. Supported by an NIH T32 grant, Anjik joined ABD to gain hands-on experience in client engagement, contract negotiation, and the CRO landscape. He brings a strong interest in translational impact, public outreach, and advancing equitable access to research. At ABD, Anjik helps bridge science and business by supporting client strategy and early-stage innovation.

Clementine Thomas

Business Development Associate 

Clementine Thomas is a Business Development Associate at American Business Development (ABD), where she supports outreach and execution efforts across client engagements. She is currently pursuing her Ph.D. in Pharmacology & Physiology at Georgetown University and previously earned her bachelor’s degree in Neurobiology, Physiology, and Behavior from UC Davis, with a minor in Economics. Clementine holds leadership and mentoring roles within her academic community and brings strengths in communication, project management, and strategic thinking. At ABD, she leverages her multidisciplinary background to support life sciences clients navigating commercialization and growth.

Kyle Kaeo

Business Development Associate 

Kyle Kaeo is a Business Development Associate at ABD and a Ph.D. candidate in Chemical Engineering at Johns Hopkins University. His research centers on protein-based therapies for solid tumors and autoimmune diseases, and he has contributed to high-impact projects at the interface of immunology and engineering. Beyond the lab, Kyle leads doctoral recruitment efforts at the Whiting School of Engineering and has mentored students across Baltimore. At ABD, he brings together scientific fluency, people-focused leadership, and a sharp eye for commercialization strategy to help clients craft compelling value propositions and partnerships.

Jahnelle Jackson

Business Development Associate 

Jahnelle Jackson is a Business Development Associate at American Business Development and a Ph.D. candidate in Pathobiology & Translational Science at UNC-Chapel Hill. Her dissertation contributes to the Age-Based Genomic Screening (ABGS) project, focusing on caregiver perspectives and the timing of pediatric genetic screening. A passionate science communicator, Jahnelle has experience working with diverse communities and building inclusive spaces in biotech. She recently served as Co-Managing Director of Nucleate RTP, supporting early-stage biotech teams and developing ecosystem partnerships. At ABD, she draws on her strengths in stakeholder engagement and translational strategy to advance mission-driven innovation.

Issa Kildani

Executive Consultant, M&A

Issa Kildani is a strategic and M&A advisor. With a background spanning biomedical research, regulatory affairs, and corporate strategy, Issa has advised global pharma, medtech startups, and PE-backed ventures on market expansion, investor readiness, and cross-border deal execution. He blends deep domain expertise with a forward-thinking approach, helping clients position assets for strategic exits or scale. Whether navigating regulatory hurdles or building AI-driven M&A platforms, Issa operates at the intersection of innovation, capital, and commercialization.

Daniel Dacey

Executive Consultant, Greater Boston Strategy & Parternships

Daniel Dacey is a PhD Biologist with a diverse background. He began his career in clinical laboratory science and molecular diagnostics, gaining firsthand experience with how diagnostic data is generated, validated, and interpreted in real world hospital settings. He has since transitioned into the data science and infrastructure space, where he designs scientific data architecture, builds reproducible analytical and bioinformatics workflows, implements compliant cloud environments, and advises biotechnology companies on data strategy, technical diligence, investment readiness, and regulatory positioning. His work spans early discovery through clinical readiness across therapeutics, diagnostics, and scientific instrumentation.

In parallel, Daniel builds and convenes high caliber scientific ecosystems through curated industry events, international collaborations, and cross sector partnerships. Operating out of Boston, where he hosts the majority of his events while also programming in other major innovation hubs, he works closely with founders, investors, operators, and institutional leaders to surface emerging themes, facilitate strategic introductions, and create forums where science, capital, and commercialization align. This dual perspective allows him to help organizations enter and navigate the Greater Boston market with both technical credibility and meaningful network traction.

Bryan Poltilove

Executive Consultant, Research Tools and Reagents

Mr. Poltilove serves as an advisor, consultant, and independent Board Director, helping life science tools companies with fund-raising, commercialization, and partnership strategies. Previously, as Operating Partner with BroadOak Capital Partners, Mr. Poltilove led the firm’s investment strategy in Cell and Gene Therapy, Bioproduction, and Cell Biology. Mr. Poltilove joined BroadOak after 12 years with Thermo Fisher Scientific where he served as Vice President and General Manager. Mr. Poltilove started up and led long-range strategy and day-to-day operations for the company’s cell and gene therapy business. He built a team that delivered 50%+ annual growth and championed the acquisition of Brammer Bio. Prior to Thermo Fisher, Mr. Poltilove served as Director of Revenue Strategy & Operations at the Corporate Executive Board and also held several commercial strategy roles with Johnson & Johnson. He holds Bachelor’s degrees in Chemical Engineering and Economics from the Massachusetts Institute of Technology as well as an MBA from the J.L. Kellogg School of Management at Northwestern University.

Lauren Bechara

Business Development Associate

Lauren Bechara is a biotechnology professional with a strong foundation in biochemistry, clinical laboratory operations, and business-focused life sciences training. She holds a B.S. in Biochemistry from the University of Delaware and is pursuing a Master of Biotechnology at Georgetown University, where she focuses on commercialization, drug development, and strategic decision-making in the biotech industry. Lauren has experience in academic research and clinical healthcare settings, giving her a well-rounded perspective on the translation of science from bench to bedside. She is especially interested in bridging complex scientific innovation with business strategy and facilitating communication between technical and non-technical teams.

Kavin Kirupanandasamy

Business Development Associate

Kavin Kirupanandasamy is a Business Development Associate at American Business Development (ABD) and is currently pursuing her Master’s in Biotechnology (BioBusiness track) at Georgetown University. She earned her B.Sc. (Hons) in Biomedical Sciences in India, where she developed a strong foundation in the biological sciences and translational research.

Through her graduate training, Kavin is expanding her expertise across the full spectrum of the biotech business landscape, specializing in market strategy, client engagement, competitive analysis, and strategic growth initiatives. At ABD, she supports business development efforts across client engagements, contributing to outreach, strategic positioning, and broader execution initiatives.

Kavin brings a science-driven perspective and a holistic interest in the business of life sciences, with a focus on understanding how innovation, partnerships, and strategic planning drive sustainable growth in emerging biotech companies.

Marisol Londoño Castaño

Executive Consultant, LATAM Market Acces

Marisol is a Strategic Leader at ABD LATAM and the Founder of CÓDICE Clinical Research Strategic, where she specializes in managing multidisciplinary projects within the healthcare ecosystem. By merging business acumen with a deep-seated ethical framework, Marisol spearheads the development of commercial models and go-to-market strategies that drive the sustainable growth of clinical services and research assets in both national and international markets.

Before founding CÓDICE and joining the ABD team, Marisol spent over 15 years building a distinguished career in healthcare and clinical research. She served as a Project Leader at the Fundación Universidad de Antioquia, overseeing complex clinical trials and strategic alliances with multinational corporations while ensuring strict adherence to key performance indicators (KPIs) and regulatory standards. Her previous experience includes serving as a Regulatory Affairs Advisor for the Neurosciences Group of Antioquia (GNA) and coordinating high-impact clinical trial projects.

Marisol is a Ph.D. Candidate in Philosophy (Medical Anthropology and Bioethics) and holds a Master’s degree in Bioethics and Law from the Universidad Pontificia Bolivariana. She is a Business Administrator with specialized training in Data Science and Artificial Intelligence applied to public sector challenges.

In addition to her executive leadership, Marisol is a University Professor of Bioethics and Research Ethics at the University of Antioquia. Her professional and academic excellence has been internationally recognized by the Alzheimer’s Association, earning her multiple awards and research grants for her work on the impact of genetic counseling in Latin America.

Jairo Alonso Mesa Arango

Executive Consultant, LATAM Market Acces

Jairo Alonso is our premier scientist and strategic executive with over 15 years of experience leading research, development, and innovation (R+D+i) projects across the biotechnological and clinical sectors. As Chief Molecular Scientist at ABD LATAM, he serves as a critical bridge between scientific innovation and commercial viability, specializing in the implementation of molecular solutions in areas of molecular diagnostics for infectious diseases, genetics, and oncology.

Across all his roles, Jairo provides significant value through specialized scientific consultancy for physicians, institutions, and patients, facilitating the interpretation of complex results and informed clinical decision-making. Through both the Scientific Direction at CIDEGEN and the Molecular Pathology Direction at LCH, he leads scientific-commercial relations with HMOs, healthcare providers, and reference laboratories, while managing strategic alliances with leading multinational genomic technology companies for high-value equipment and reagent negotiations.

As head of the R+D+A unit at LCH, he has spearheaded diagnostic modernization through the standardization of high-complexity protocols ranging from specialized nucleic acid extraction to workflows in qPCR, Sanger Sequencing, FISH, and Next-Generation Sequencing (NGS). His leadership is characterized by the implementation of POCT platforms and open systems, enabling the deployment of comprehensive solutions for detecting critical pathogens (respiratory, gastrointestinal, and STIs), molecular screening for cancer prevention and diagnosis, and the study of genetic mutations and high-impact gene expression levels. This technological versatility allows him to lead the delivery of cutting-edge molecular assays integrated into routine clinical practice.

He holds a Ph.D. in Biology (Biochemistry and Molecular Parasitology), a period during which he developed advanced technical expertise in genetic engineering and molecular cloning. His scientific publications underscore his leadership in the design and production of recombinant chimeric antigens, establishing his work as a benchmark for diagnostic protein production hubs in Latin America. He coordinates the Teaching-Service ecosystem with top-tier universities, integrating academic excellence with operational rigor to transform personalized medicine across the region.

Ángela María Restrepo Aristizábal, MBA

Executive Consultant, LATAM Market Acces

Ángela María is a lawyer and executive leader with over 15 years of experience in legal management, legal structuring, and leading high-impact projects. As Legal Director at CÓDICE, she serves as a strategic pillar, ensuring the protection, viability, and success of corporate operations, while bringing a managerial perspective supported by her Master of Business Administration (MBA). Her primary expertise lies in public and private contracting and negotiation, where she designs legal frameworks that enable the company’s growth and expansion.

Her distinguished career in private-sector organizations, where she has held senior executive roles, positions her as an expert in leading initiatives with both national and international scope. In this context, Ángela María has orchestrated the legal structuring, execution, and oversight of complex public budgets, facilitating the development of mega-projects and strategic partnerships among the public sector, academia, and private industry. Her ability to navigate dense regulatory and administrative environments is a key asset for CÓDICE’s institutional relationships.

In addition to her corporate role, Ángela María is a Specialist in Labor Law and demonstrates a strong vocation as a negotiator. This combination of academic rigor and business practice enables her to lead complex negotiations, manage multidisciplinary teams, and ensure regulatory compliance with a results-oriented approach. At CÓDICE, her leadership not only mitigates legal risks but also transforms the legal function into a driver of competitiveness and trust for clients, insurers, multinational companies, and strategic partners.